| Line Item | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Total revenue | ||||
| Operating expenses: | ||||
| Direct cost of sales, excluding depreciation and amortization | ||||
| Indirect cost of sales and other expenses, excluding depreciation and amortization | ||||
| Selling, general and administrative | ||||
| Research and development | ||||
| Depreciation and amortization | ||||
| Total operating expenses | ||||
| % of revenue | 123.2% | 111.3% | ||
| Income (loss) from operations | ||||
| % of revenue | -23.2% | -11.3% | ||
| Other income (expense): | ||||
| Interest income | ||||
| Interest expense | ||||
| Loss from changes in fair value of financial liabilities | ||||
| Loss from extinguishment of debt | — | |||
| Other income (expense), net | ||||
| Total other income (expense), net | ||||
| Income (loss) before benefit for income taxes | ||||
| Income tax expense | ||||
| Net income (loss) | ||||
| % of revenue | -30.7% | -18.1% | ||
| Preferred stock dividend | ||||
| Income allocated to participating securities | ||||
| Net loss attributable to common stockholders, basic | ||||
| Net loss attributable to common stockholders, diluted | ||||
| Net loss per share, basic (in dollars per share) | ||||
| Net loss per share, diluted (in dollars per share) |